Boesing, C.; Graf, P.T.; Thiel, M.; Luecke, T.; Krebs, J.
Procollagen I and III as Prognostic Markers in Patients Treated with Extracorporeal Membrane Oxygenation: A Prospective Observational Study. J. Clin. Med. 2021, 10, 3686.
https://doi.org/10.3390/jcm10163686
AMA Style
Boesing C, Graf PT, Thiel M, Luecke T, Krebs J.
Procollagen I and III as Prognostic Markers in Patients Treated with Extracorporeal Membrane Oxygenation: A Prospective Observational Study. Journal of Clinical Medicine. 2021; 10(16):3686.
https://doi.org/10.3390/jcm10163686
Chicago/Turabian Style
Boesing, Christoph, Peter T. Graf, Manfred Thiel, Thomas Luecke, and Joerg Krebs.
2021. "Procollagen I and III as Prognostic Markers in Patients Treated with Extracorporeal Membrane Oxygenation: A Prospective Observational Study" Journal of Clinical Medicine 10, no. 16: 3686.
https://doi.org/10.3390/jcm10163686
APA Style
Boesing, C., Graf, P. T., Thiel, M., Luecke, T., & Krebs, J.
(2021). Procollagen I and III as Prognostic Markers in Patients Treated with Extracorporeal Membrane Oxygenation: A Prospective Observational Study. Journal of Clinical Medicine, 10(16), 3686.
https://doi.org/10.3390/jcm10163686